Daewoong pharmaceutical Co.,Ltd (069620.KS)
KRW 125500.0
(-2.64%)
KRW 125500.0
(-2.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 131 Billion | 118.21 Billion | 39.99 Billion | 100.98 Billion | 57.6 Billion | 47.49 Billion |
| Net Income | 121.73 Billion | 39.16 Billion | 30.25 Billion | 24.14 Billion | 28.86 Billion | -15.41 Billion |
| Depreciation & Amortization | 42.7 Billion | 39.69 Billion | 40.88 Billion | 40.88 Billion | 40.19 Billion | 51.3 Billion |
| Deferred income taxes | -72.75 Billion | - | -7.18 Billion | -383.33 Million | -8.93 Billion | 43.05 Billion |
| Stock-based compensation | 252.71 Million | 1.84 Billion | 2 Billion | 1.19 Billion | 943.21 Million | 633.05 Million |
| Change in working capital | -25.71 Billion | 31.58 Billion | -29.85 Billion | 27.95 Billion | -14.9 Billion | -39.49 Billion |
| Other non-cash items | 64.78 Billion | 5.93 Billion | 3.88 Billion | 7.18 Billion | 11.43 Billion | 7.41 Billion |
| Investing Cash Flow | -165.62 Billion | -106.87 Billion | -87.68 Billion | -127.15 Billion | -85.6 Billion | -68.61 Billion |
| Investments in PPE | -156.17 Billion | -113.3 Billion | -74.79 Billion | -59.69 Billion | -50.1 Billion | -57.06 Billion |
| Acquisitions | -4.28 Billion | -8.96 Billion | -572.21 Million | -1 Billion | -1.12 Billion | -6.6 Billion |
| Investment purchases | -18.85 Billion | -23.59 Billion | -319 Billion | -448.72 Billion | -225.85 Billion | -234 Billion |
| Sales/Maturities of investments | 13.15 Billion | 30.57 Billion | 306.35 Billion | 362.14 Billion | 189.84 Billion | 223.1 Billion |
| Other Investing Activities | 534.99 Million | 8.42 Billion | 330.51 Million | 20.12 Billion | 1.63 Billion | 5.94 Billion |
| Financing Cash Flow | 39.21 Billion | 15.51 Billion | 50.22 Billion | 66.58 Billion | -5.66 Billion | -4.77 Billion |
| Debt repayment | -1.14 Billion | -201.21 Billion | -143.25 Billion | -94.35 Billion | -202.56 Billion | -93.39 Billion |
| Dividends payments | -7.27 Billion | -6.64 Billion | -6.45 Billion | -6.19 Billion | -6.19 Billion | -6.19 Billion |
| Common Stock Repurchased | -2.24 Billion | - | 140.95 Billion | 141.94 Billion | - | - |
| Common Stock Issuance | 49.88 Billion | - | 40.24 Billion | 29.98 Billion | - | - |
| Other Financing Activities | -10.00 | 224.79 Billion | 18.73 Billion | -4.79 Billion | 203.09 Billion | 94.8 Billion |
| Accounts receivables | -3.69 Billion | -24.4 Billion | -27.91 Billion | 53.91 Billion | -22.12 Billion | -11.98 Billion |
| Accounts payables | 16.59 Billion | 12.4 Billion | -8.37 Billion | 1.86 Billion | 12.6 Billion | 2.51 Billion |
| Inventory | -36.58 Billion | 40.55 Billion | 58.18 Million | - | 5.4 Billion | -11.27 Billion |
| Other working capital | -2.03 Billion | 3.01 Billion | 6.37 Billion | -27.83 Billion | -10.78 Billion | -28.22 Billion |
| Cash at beginning of period | 102.95 Billion | 75.9 Billion | 72.29 Billion | 32.09 Billion | 65.33 Billion | 91.12 Billion |
| Cash at end of period | 111.5 Billion | 102.95 Billion | 75.9 Billion | 72.29 Billion | 32.09 Billion | 65.33 Billion |
| Capital Expenditure | -156.17 Billion | -113.3 Billion | -74.79 Billion | -59.69 Billion | -50.1 Billion | -57.06 Billion |
| Effect of forex changes on cash | -291.64 Million | 184.47 Million | 1.07 Billion | -211.65 Million | 425.49 Million | 110.17 Million |
| Net cash flow / Change in cash | 8.55 Billion | 27.04 Billion | 3.6 Billion | 40.2 Billion | -33.23 Billion | -25.78 Billion |
| Free Cash Flow | -25.16 Billion | 4.9 Billion | -34.8 Billion | 41.28 Billion | 7.49 Billion | -9.56 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.14 Billion | 8.14 Billion | 66 Billion | 121.73 Billion | 15.25 Billion | 28.75 Billion |
| Depreciation & Amortization | 12 Billion | 11.53 Billion | 11.5 Billion | 42.7 Billion | 10.97 Billion | 10.82 Billion |
| Deferred income taxes | - | - | - | -72.75 Billion | 11.22 Billion | 3.57 Billion |
| Stock-based compensation | 33.21 Million | 252.92 Million | - | 252.71 Million | 369.71 Million | 949.68 Million |
| Change in working capital | -24.63 Billion | -23.76 Billion | -29.44 Billion | -25.71 Billion | 23.26 Billion | -13.31 Billion |
| Other non-cash items | 2.11 Billion | 42.78 Billion | -8.38 Billion | 64.78 Billion | 3.39 Billion | 1.95 Billion |
| Investing Cash Flow | -77.54 Billion | -57.9 Billion | -71.39 Billion | -165.62 Billion | -31.98 Billion | -26.32 Billion |
| Investments in PPE | -38.37 Billion | -56.31 Billion | -65.36 Billion | -156.17 Billion | -39.37 Billion | -19.75 Billion |
| Acquisitions | 5.84 Million | 97.8 Million | -4.6 Billion | -4.28 Billion | -19.51 Billion | 632.81 Million |
| Investment purchases | -17.76 Billion | -6.68 Billion | -3.45 Billion | -18.85 Billion | -569.46 Million | -7.7 Billion |
| Sales/Maturities of investments | -4.92 Billion | 4.99 Billion | 2.02 Billion | 13.15 Billion | 11.12 Billion | -632.81 Million |
| Other Investing Activities | -39.16 Billion | 1.05 Million | 1.04 Million | 534.99 Million | 16.35 Billion | 1.13 Billion |
| Financing Cash Flow | 68.53 Billion | 35.09 Billion | 28.2 Billion | 39.21 Billion | -1.1 Billion | -34.76 Billion |
| Debt repayment | -569.02 Million | -35.65 Billion | -28.81 Billion | -1.14 Billion | -78.54 Million | -63.86 Billion |
| Dividends payments | -6.9 Billion | - | -2.96 Million | -7.27 Billion | -639.29 Million | -6.64 Billion |
| Common Stock Repurchased | - | - | - | -2.24 Billion | - | - |
| Common Stock Issuance | - | - | - | 49.88 Billion | - | - |
| Other Financing Activities | 76.38 Billion | 97.8 Million | -606.42 Million | -10.00 | -387.23 Million | 35.73 Billion |
| Accounts receivables | -33.55 Billion | 14.82 Billion | -10.3 Billion | -3.69 Billion | -7.92 Billion | 3.76 Billion |
| Accounts payables | -4.79 Billion | -14.41 Billion | 2.18 Billion | 16.59 Billion | 8.28 Billion | -16.61 Billion |
| Inventory | -12.27 Billion | - | 33.98 Billion | -36.58 Billion | -9.84 Billion | -23.34 Billion |
| Other working capital | 21.19 Billion | -24.16 Billion | -55.3 Billion | -2.03 Billion | 32.74 Billion | 22.88 Billion |
| Cash at beginning of period | 105.76 Billion | 111.5 Billion | 143.77 Billion | 102.95 Billion | 112.5 Billion | 140.84 Billion |
| Cash at end of period | 87.67 Billion | 105.76 Billion | 111.5 Billion | 111.5 Billion | 143.77 Billion | 112.5 Billion |
| Capital Expenditure | -38.37 Billion | -56.31 Billion | -65.36 Billion | -156.17 Billion | -39.37 Billion | -19.75 Billion |
| Effect of forex changes on cash | 266.91 Million | 1.02 Billion | 2.36 Billion | -291.64 Million | -119.82 Million | -2.21 Million |
| Net cash flow / Change in cash | -18.08 Billion | -5.73 Billion | -32.27 Billion | 8.55 Billion | 31.27 Billion | -28.34 Billion |
| Free Cash Flow | -47.72 Billion | -40.27 Billion | -56.81 Billion | -25.16 Billion | 25.1 Billion | 12.98 Billion |
TCRRF
KHRNF
6054
014580
XELPMOC
300694